AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-229057980/helix-biopharma-corp-announces.html" title="Facts and information about Helix BioPharma Corp announces Phase II clinical trial results of Topical Interferon Alpha-2b in patients with ano-genital warts.">Helix BioPharma Corp announces Phase II clinical trial results of Topical Interferon Alpha-2b in patients with ano-genital warts.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Helix BioPharma Corp announces Phase II clinical trial results of Topical Interferon Alpha-2b in patients with ano-genital warts.
Helix BioPharma Corp announced results from the Phase II clinical trial assessing the efficacy and safety of Topical Interferon Alpha-2b cream for the treatment of ano-genital warts. Analysis of the primary study endpoint, that is, the proportion of patients with complete clearance of their baseline lesions during the eight week treatment period, as well as the secondary efficacy endpoints, showed no statistically significant …
Related articles from newspapers, magazines, journals, and more
-
- Helix Biopharma files IND for its planned Phase II/III efficacy trial of...
-
News wire article from: Chemical Business Newsbase
October 19, 2010
700+ words
-
- Helix Biopharma reports positive efficacy and safety findings from Phase II...
-
News wire article from: Chemical Business Newsbase
October 21, 2010
700+ words
-
- Helix BioPharma Corp achieves last-patient-out in its Phase II trial of...
-
News wire article from: Chemical Business Newsbase
March 22, 2010
700+ words
-
- Helix BioPharma provides updates on topical interferon alpha-2b and L-DOS47...
-
News wire article from: Chemical Business Newsbase
October 6, 2009
700+ words
-
- Helix receives approval to open sites in Germany for its ongoing clinical...
-
News wire article from: Chemical Business Newsbase
September 22, 2008
700+ words
